Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2026)

Immatics (IMTX) posted Non-Current Deferred Tax Liability of $4.4 million for Q4 2025, up 3.06% sequentially from $4.3 million in Q3 2025, and down 28.55% YoY from $6.2 million in Q4 2024.

Analysis

Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends

Immatics has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $4.4 million in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 28.55% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (down 28.55% YoY) and the FY2025 annual result came in at $4.3 million, down 31.53% from the prior year.
  • Non-Current Deferred Tax Liability advanced to $4.4 million in Q4 2025 per IMTX's latest filing, from $4.3 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $10.0 million in Q4 2022 and troughed at $3.7 million in Q3 2024.
  • A 4-year average of $6.0 million and a median of $5.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 16.59% in 2025, down 39.56% in 2025.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $10.0 million in 2022, then fell by 19.75% to $8.0 million in 2023, then slipped by 22.79% to $6.2 million in 2024, then slipped by 28.55% to $4.4 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $4.4 million, $4.3 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.17 Mn
Mar 31, 2026 4.52 Mn
Dec 31, 2025 4.43 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 4.31 Mn
Mar 31, 2025 5.06 Mn
Dec 31, 2024 6.20 Mn
Sep 30, 2024 3.69 Mn
Jun 30, 2024 7.13 Mn
Mar 31, 2024 7.23 Mn
Dec 31, 2023 8.03 Mn
Dec 31, 2022 10.01 Mn